Magnus Gram

Magnus Gram is an active Associate Professor in the Department of Paediatrics at Lund University's Faculty of Medicine, where he serves as a Principal Investigator in Neonatology and Redox Medicine. His academic profile shows extensive research contributions with 93 publications across multiple disciplines within pediatric medicine.

Dr. Gram's research primarily focuses on neonatal neuroprotection, with particular expertise in Alpha-1-microglobulin (A1M), intraventricular hemorrhage, and redox pharmaceutical therapies for newborns. His work spans several critical areas including pre-eclampsia, hemoglobin biology, and insulin-like growth factor 1 (IGF-1) applications in immature brain development. The research fingerprint shows strong connections to microglobulin biochemistry, cellular mechanisms, and scavenger functions in neonatal conditions.

His publication record demonstrates consistent research productivity with recent work spanning medical technology innovations, blood-brain barrier dynamics, and novel therapeutic approaches for premature infants. The research trends indicate a strong interdisciplinary approach combining molecular medicine, neonatology, and redox biology to address critical challenges in newborn care.

• Best Poster Award (2023)
• Finalist, Lund University and Sparbanksstiftelsen Finn's prize for future innovations (2017)

Dr. Gram actively supervises research work with 6 supervised projects documented, and leads or participates in multiple research initiatives including the 'Development of hemoglobin based oxygen carriers' and 'A1M: Protective mechanisms and therapeutic potential of A1M' projects. His collaborative network extends internationally, with recent external collaborations across multiple countries. His laboratory work focuses on neonatal redox medicine, particularly investigating A1M's protective mechanisms and therapeutic applications for conditions like intraventricular hemorrhage in premature infants.